Solara Active Pharma Sciences Limited (NSE:SOLARA)
India · Delayed Price · Currency is INR 547.40
+14.70 (2.76%)
Jun 1, 2026, 3:30 PM IST
NSE:SOLARA Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -74.1 | 5.4 | -5,674 | -221.8 | -581.5 |
Depreciation & Amortization | 996.8 | 974.8 | 1,011 | 1,066 | 1,081 |
Other Amortization | - | 17.7 | 21.9 | 46.1 | 41.9 |
Loss (Gain) From Sale of Assets | 2.6 | - | 19.7 | 4.5 | 7.7 |
Asset Writedown & Restructuring Costs | - | 0.8 | 25.3 | - | - |
Stock-Based Compensation | 46.7 | 26.8 | 6 | 0.5 | -13.1 |
Provision & Write-off of Bad Debts | 39.4 | 10.2 | 109.9 | 56.6 | 88.2 |
Other Operating Activities | 899.4 | 1,062 | 3,662 | 603.4 | 93.1 |
Change in Accounts Receivable | -1,113 | 198.1 | 1,782 | -528 | -145.5 |
Change in Inventory | 0.3 | 418 | 130.8 | 173.2 | -2,806 |
Change in Accounts Payable | 259 | -594.3 | 73 | 389 | -238.8 |
Change in Other Net Operating Assets | 472.2 | 8.4 | -79.2 | -26.8 | 52.2 |
Operating Cash Flow | 1,529 | 2,128 | 1,089 | 1,563 | -2,420 |
Operating Cash Flow Growth | -28.15% | 95.48% | -30.32% | - | - |
Capital Expenditures | -528.2 | -399.4 | -410.6 | -1,113 | -2,086 |
Sale of Property, Plant & Equipment | 5.1 | 3.8 | 10.4 | 13 | 1.3 |
Divestitures | - | 9.6 | - | - | - |
Investment in Securities | -486.2 | - | - | -12.8 | - |
Other Investing Activities | 21 | 17.7 | 41.6 | 125 | -343.6 |
Investing Cash Flow | -988.3 | -368.3 | -35.1 | -811.4 | -2,429 |
Short-Term Debt Issued | - | - | 1,115 | 394.4 | 2,487 |
Long-Term Debt Issued | 495 | 750 | 49 | 683 | 2,624 |
Total Debt Issued | 495 | 750 | 1,164 | 1,077 | 5,111 |
Short-Term Debt Repaid | -768.1 | -1,854 | - | - | - |
Long-Term Debt Repaid | -925.2 | -1,131 | -1,194 | -1,331 | -962.2 |
Total Debt Repaid | -1,693 | -2,985 | -1,194 | -1,331 | -962.2 |
Net Debt Issued (Repaid) | -1,198 | -2,235 | -30.2 | -253.1 | 4,149 |
Issuance of Common Stock | 1,585 | 1,590 | - | - | 29 |
Common Dividends Paid | - | - | - | - | -107.8 |
Other Financing Activities | -922.4 | -1,160 | -1,026 | -874.5 | -734 |
Financing Cash Flow | -535.5 | -1,805 | -1,057 | -1,128 | 3,336 |
Net Cash Flow | 5.3 | -44.9 | -2.9 | -376.5 | -1,513 |
Free Cash Flow | 1,001 | 1,729 | 678.1 | 449.4 | -4,507 |
Free Cash Flow Growth | -42.10% | 154.95% | 50.89% | - | - |
Free Cash Flow Margin | 7.28% | 13.47% | 5.26% | 3.11% | -35.53% |
Free Cash Flow Per Share | 22.69 | 43.33 | 17.75 | 12.48 | -125.38 |
Cash Interest Paid | - | 1,131 | 1,035 | - | 734 |
Cash Income Tax Paid | - | 9 | -9 | -135.4 | 181 |
Levered Free Cash Flow | 232.8 | 595.65 | 2,768 | -82.46 | -5,069 |
Unlevered Free Cash Flow | 824.99 | 1,279 | 3,402 | 460.04 | -4,616 |
Change in Working Capital | -381.7 | 30.2 | 1,906 | 7.4 | -3,138 |